Seres Therapeutics Inc (NASDAQ: MCRB) has experienced a rise in its stock price by 11.01 compared to its previous closing price of 9.08. However, the
The 36-month beta value for MCRB is at 2.99. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 0
The stock of Seres Therapeutics Inc (MCRB) has seen a 13.54% increase in the past week, with a -19.98% drop in the past month, and
The stock has a 36-month beta value of 2.82. Opinions on the stock are mixed, with 4 analysts rating it as a “buy,” 0 as
The 36-month beta value for MCRB is also noteworthy at 2.53. There are mixed opinions on the stock, with 4 analysts rating it as a
In the past week, MCRB stock has gone up by 16.24%, with a monthly decline of -10.57% and a quarterly plunge of -16.62%. The volatility
© 2024, Powered by Smart TechOne
